Ptc Therapeutics (PTCT) Change in Acquisitions & Divestments (2013 - 2026)

Ptc Therapeutics' Change in Acquisitions & Divestments history runs 14 years deep, the most recent figure standing at $27.6 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments rose 235.41% year-over-year to $27.6 million; the TTM figure through Jun 2026 stood at $786.5 million (up 85.14% YoY), while the FY2025 annual figure was $783.9 million, up 42.63% from the prior year.
• Change in Acquisitions & Divestments for Q2 2026 stood at $27.6 million, down from $376.4 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $376.4 million in Q1 2026, with the low at $1.2 million in Q2 2022.
• The 5-year median for Change in Acquisitions & Divestments is $44.6 million (2024), against an average of $97.7 million.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments jumped 14300.0% in 2022, then plunged 92.52% in 2023.
• Ptc Therapeutics' Change in Acquisitions & Divestments stood at $63.2 million in 2022, then jumped by 75.01% to $110.7 million in 2023, then soared by 133.79% to $258.8 million in 2024, then surged by 38.94% to $359.5 million in 2025, then tumbled by 92.32% to $27.6 million in 2026.
• Business Quant data shows PTCT's Change in Acquisitions & Divestments at $27.6 million in Q2 2026, $376.4 million in Q1 2026, and $359.5 million in Q4 2025.